Egypt · 
Who invested in Rology?
Rology's investors include Philips Foundation, Sanofi, 54 Collective, Johnson & Johnson Impact Ventures and MIT Solve Innovation Future, and 1 more on record. Philips Foundation led its latest round.
Egypt · Growth startup
Who invested in Rology
One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 11 months ago
Follow Rology and see its new rounds in your feed. Start following
Funding summaryUpdated 5 Nov 2026
Undisclosedraised across 1 round since 2025, from 1 source
- Latest round
- GrowthDec 2025
- Led by
- Philips Foundation
- Investors
- 6 (1 led)
The rounds
- Dec 2025GrowthAmount undisclosed
Philips FoundationLead
Sanofi
54 Collective
Johnson & Johnson Impact Ventures- MIT Solve Innovation Future
- Sanofi Global Health Unit's Impact Fund
Reported by Disrupt Africa
Everyone who backed them
MIT Solve Innovation FutureGrowth equity1round
Sanofi Global Health Unit's Impact FundGrowth equity1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 3 firms list Rology as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Rology
How much has Rology raised?
Rology has raised 1 round since 2025, none with a disclosed amount.
When did Rology last raise?
Rology's most recent round was a Growth in Dec 2025, led by Philips Foundation.
Who backed Rology first?
Rology's first round on record, in Dec 2025, was backed by Philips Foundation, Sanofi and 54 Collective and 3 others.
What stage is Rology at?
Rology's latest named round is a Growth, in Dec 2025.
Where is Rology based?
Rology is based in Egypt.
Who led Rology's rounds?
Philips Foundation led the Growth in 2025.
Companies like Rology
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.